New York, Jan 3, 2026, 10:53 ET — Market closed
UnitedHealth Group Incorporated shares rose 1.9% on Friday to close at $336.40, extending a New Year rebound for the Dow component after it traded between $327.50 and $340.21.
The move matters now because UnitedHealth is set to deliver its next major catalyst this month: full-year 2025 results and 2026 financial guidance on Jan. 27, before the market opens, the company said. It will host a conference call at 8 a.m. ET.
The broader tape also turned positive in the first trading session of 2026, with the Dow up 0.66% and the S&P 500 gaining 0.19%, Reuters reported. “Buy the dip, sell the rip” has been the prevailing mentality — a strategy of buying pullbacks and selling rallies — Joe Mazzola, head of trading and derivatives strategy at Charles Schwab, told Reuters. Reuters
Managed-care peers finished higher on the day, led by Humana, which gained 3.3%. Elevance Health rose about 1.1%, Cigna added 1.4%, and CVS Health edged up about 1.0%.
For investors, the next leg is likely to hinge on guidance and medical-cost trends. In October, executives said medical costs remained elevated but in line with company expectations, while also flagging pressure in its Medicaid business as payment rates lag costs, Reuters reported.
UnitedHealth runs the UnitedHealthcare insurance business and Optum, which includes medical care delivery and pharmacy services. That mix can make the stock sensitive both to health-care utilization and to how management prices plans for the year ahead.
Optum Rx, the company’s pharmacy benefit unit, said it is reducing repeat prior authorizations — insurer approvals required before some medicines are covered — for another 40 drugs starting Jan. 1.
With U.S. markets closed Saturday and set to reopen Monday, investors will be watching for macro signals that can move defensives. Data in the week ahead include a batch of U.S. labor-market releases, including the BLS December jobs report as well as JOLTS and ADP employment figures, Trading Economics showed.
The Federal Reserve’s January calendar shows a two-day policy meeting on Jan. 27-28, with a press conference scheduled for Jan. 28. That timing puts the central bank’s rate outlook in the same week UnitedHealth is due to issue its 2026 guidance.
On the charts, traders will be watching whether UNH holds above Friday’s low and can retest the session high, as the stock settles into the first full week of 2026.
For now, the immediate focus is on what UnitedHealth says later this month about 2026 medical-cost assumptions, Medicare Advantage enrollment trends (private plans for seniors paid by the government) and any updates on Optum performance.
Until then, UNH is likely to trade with the group on rate expectations and policy headlines, while its size — and its role as a Dow component — keeps it on screens when the blue-chip index swings.
